Changes in biochemical markers of bone metabolism in male patients with human immunodeficiency virus infection during potent antiretroviral therapy

被引:0
|
作者
Teichmann, J
Lange, U
Friese, G
Discher, T
Lohmeyer, J
Stracke, H
Bretzel, RG
机构
[1] Univ Giessen Klinikum, Med Klin & Poliklin 3, D-6300 Giessen, Germany
[2] Univ Giessen Klinikum, Med Klin & Poliklin 2, D-6300 Giessen, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S212 / S212
页数:1
相关论文
共 50 条
  • [41] CLINICAL AND BASIC ADVANCES IN THE ANTIRETROVIRAL THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    YARCHOAN, R
    MITSUYA, H
    BRODER, S
    [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 87 (02): : 191 - 200
  • [42] Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection
    Menendez-Arias, Luis
    Alvarez, Mar
    [J]. ANTIVIRAL RESEARCH, 2014, 102 : 70 - 86
  • [43] Association between inflammatory markers and microbial translocation in patients with human immunodeficiency virus infection taking antiretroviral treatment
    Reus Banuls, Sergio
    Portilla Sogorb, Joaquin
    Sanchez-Paya, Jose
    Boix Martinez, Vicente
    Giner Oncina, Livia
    Frances, Ruben
    Such, Jose
    Merino Lucas, Esperanza
    Gimeno Gascon, Adelina
    [J]. MEDICINA CLINICA, 2014, 142 (02): : 47 - 52
  • [44] Prevalence of Plantar Verrucae in Patients with Human Immunodeficiency Virus Infection During the Post-Highly Active Antiretroviral Therapy Era
    Johnston, James
    King, Christy M.
    Shanks, Sky
    Khademi, Saieh
    Nelson, Joseph
    Yu, Jenny
    Barbosa, Peter
    [J]. JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2011, 101 (01) : 35 - 40
  • [45] Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type I infection
    Gibb, DM
    Duong, T
    Leclezio, VA
    Walker, AS
    Verweel, G
    Dunn, DT
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (05) : 446 - 450
  • [46] Clinical and immunologic outcome in patients with human immunodeficiency virus infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy
    Abgrall, S
    Duval, X
    Joly, V
    Descamps, D
    Matheron, S
    Costagliola, D
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (11) : 1517 - 1526
  • [47] Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy
    Singh, N
    Berman, SM
    Swindells, S
    Justis, JC
    Mohr, JA
    Squier, C
    Wagener, MM
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (04) : 824 - 830
  • [48] Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients
    Turner, BJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 : S143 - S151
  • [49] Epidemiology and Outcomes in Critically Ill Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy
    Turvey, Shannon L.
    Bagshaw, Sean M.
    Eurich, Dean T.
    Sligl, Wendy I.
    [J]. CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2017, 2017 : 1 - 9
  • [50] Role of Upper Gastrointestinal Endoscopy in Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy
    Kang, Jin Suk
    Lee, Sun Hee
    Lee, Shinwon
    Kim, Gwang Ha
    Park, Young Joo
    Han, In Sub
    Lee, Jeong Eun
    Lee, Soon Ok
    Moon, Chisook
    [J]. INFECTION AND CHEMOTHERAPY, 2019, 51 (01): : 35 - 44